Richard Torbett spoke to the MMIP Annual Conference about the future of UK medicines manufacturing.
The ABPI 2021 Code of Practice comes into force from 1 July, alongside new ABPI Principles to help companies operate to high ethical standards.
A new partnership to ensure the world is better protected against future pandemics has been launched at the G7.
The global pharmaceutical industry welcomes the G7 Health and Finance meeting communiqués and the commitment to address AMR, one of the top 10 global public health threats facing humanity.
The UK Government has pledged to donate at least 100 million surplus coronavirus vaccine doses within the next year, including 5 million beginning in the coming weeks.
The global pharmaceutical industry welcomes today’s communiqué and the commitment by G7 partners to future discussions on trade and health.
Innovative vaccine manufacturers and biotech companies are at the forefront of the global effort to develop and manufacture COVID-19 vaccines. This massive effort is succeeding.
PMCPA Director, Heather Simmonds, has announced that she will leave the PMCPA at the end of December 2022.
The Queen’s Speech has outlined the government’s legislative agenda for the coming year.
The United States has said it will support a proposal to waive intellectual property and patents on COVID-19 vaccines.